Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-09-10
著者
-
Cortes Jorge
Department Of Leukemia Unit 428 The University Of Texas M. D. Anderson Cancer Center
-
Cortes Jorge
Department Of Leukemia M.d. Anderson Cancer Center
-
Jabbour Elias
Department Of Leukemia The University Of Texas M. D. Anderson Cancer Center
-
YIN C.
Department of Hematopathology, the University of Texas M. D. Anderson Cancer Center
-
GALBINCEA John
Department of Hematopathology, the University of Texas M. D. Anderson Cancer Center
-
REDDY Neelima
Department of Hematopathology, the University of Texas M. D. Anderson Cancer Center
-
BREEDEN Megan
Department of Hematopathology, the University of Texas M. D. Anderson Cancer Center
-
LUTHRA Rajyalakshmi
Department of Hematopathology, the University of Texas M. D. Anderson Cancer Center
-
JONES Dan
Department of Hematopathology, the University of Texas M. D. Anderson Cancer Center
-
Yin C.
Department Of Hematopathology The University Of Texas M. D. Anderson Cancer Center
-
Jones Dan
Department Of Hematopathology The University Of Texas M. D. Anderson Cancer Center
-
Cortes Jorge
Department Of Leukemia The University Of Texas M. D. Anderson Cancer Center
-
Breeden Megan
Department Of Hematopathology The University Of Texas M. D. Anderson Cancer Center
-
Reddy Neelima
Department Of Hematopathology The University Of Texas M. D. Anderson Cancer Center
-
Galbincea John
Department Of Hematopathology The University Of Texas M. D. Anderson Cancer Center
-
Luthra Rajyalakshmi
Department Of Hematopathology The University Of Texas M. D. Anderson Cancer Center
関連論文
- Incidence of extramedullary disease in patients with acute promyelocytic leukemia : a single-institution experience
- Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation
- Imatinib mesylate therapy for polycythemia vera : final result of a phase II study initiated in 2001
- The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2^ mutation
- Sensitivity of human cells bearing oncogenic mutant kit isoforms to the novel tyrosine kinase inhibitor INNO-406
- Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan
- New Strategies in Chronic Myeloid Leukemia
- Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays
- Imatinib Mesylate in the Treatment of Chronic Myelogenous Leukemia